Evidence map›Paper›PMID 26984849›Full record

ReviewJournal of clinical immunology2016

Dissecting Epigenetic Dysregulation of Primary Antibody Deficiencies.

Virginia C Rodríguez-Cortez, Lucia Del Pino-Molina, Javier Rodríguez-Ubreva, Eduardo López-Granados, Esteban Ballestar

Abstract readReview
PubMed Publisher
In one paragraph

Review in Journal of clinical immunology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.4field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Review
  9. Ins and Outs of Antibodies.Journal of clinical immunology · 2016
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Virginia C Rodríguez-CortezChromatin and Disease Group, Cancer Epigenetics and Biology Programme (PEBC), Bellvitge Biomedical Research Institute (IDIBELL), 08908 L'Hospitalet de Llobregat, Barcelona, Spain.
Lucia Del Pino-MolinaClinical Immunology Department, University Hospital La Paz, Paseo de la Castellana 261, 28046, Madrid, Spain.
Javier Rodríguez-UbrevaChromatin and Disease Group, Cancer Epigenetics and Biology Programme (PEBC), Bellvitge Biomedical Research Institute (IDIBELL), 08908 L'Hospitalet de Llobregat, Barcelona, Spain.
Eduardo López-GranadosClinical Immunology Department, University Hospital La Paz, Paseo de la Castellana 261, 28046, Madrid, Spain.
Esteban BallestarChromatin and Disease Group, Cancer Epigenetics and Biology Programme (PEBC), Bellvitge Biomedical Research Institute (IDIBELL), 08908 L'Hospitalet de Llobregat, Barcelona, Spain. eballestar@idibell.cat.
Institut d'Investigació Biomédica de Bellvitge · ESHospital La Paz Institute for Health Research · ESHospital Universitario La Paz · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Primary antibody deficiencies (PADs), the most prevalent inherited primary immunodeficiencies (PIDs), are associated with a wide range of genetic alterations (both monogenic or polygenic) in B cell-specific genes. However, correlations between the genotype and clinical manifestations are not evident in all cases indicating that genetic interactions, environmental and epigenetic factors may have a role in PAD pathogenesis. The recent identification of key defects in DNA methylation in common variable immunodeficiency as well as the multiple evidences on the role of epigenetic control during B cell differentiation, activation and during antibody formation highlight the importance of investing research efforts in dissecting the participation of epigenetic defects in this group of diseases. This review focuses on the role of epigenetic control in B cell biology which can provide clues for the study of potential novel pathogenic defects involved in PADs.

Indexed as

Epigenesis, GeneticGene Expression RegulationGenetic Association StudiesGenetic Predisposition to DiseaseAgammaglobulinemiaAnimalsAntibody AffinityAntibody FormationB-LymphocytesCell DifferentiationDNA MethylationHistonesHumansImmunologic Deficiency SyndromesLymphocyte ActivationMutationHistonesB lymphocytesDNA methylationEpigeneticsHistone modificationsPrimary Antibody DeficienciesPrimary Immunodeficiencies

Identifiers

PMID26984849
OpenAlexW2298809004

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.